Open access · CC-BY
via OpenAlex
The Protective Role of Klotho in CKD-Associated Cardiovascular Disease
Xianjin Bi, Ke Yang, Bo Zhang, Jinghong Zhao
Kidney Diseases · 2020 · ▲ 50 citations
Abstract
BACKGROUND: Cardiovascular diseases (CVDs) are the leading cause of morbidity and mortality in advanced CKD. The major pathological changes of CKD-associated CVD are severe vascular media calcification, aberrant cardiac remodeling such as hypertrophy and fibrosis, as well as accelerated atherosclerosis. α-Klotho is proposed as an anti-aging gene, which is primarily expressed in the kidney. Recent studies reveal that α-Klotho deficiency is associated with profound cardiovascular dysfunction. Of note, CKD represents extremely declined α-Klotho levels, hinting that α-Klotho deficiency may be implicated in the pathogenesis of CKD-associated CVD. SUMMARY: Based on the pathogenic mechanism of α-Klotho deficiency and decreased Klotho levels in the circulation even early in stage 1 of CKD, α-Klotho serves as a sensitive biomarker for renal insufficiency and also a novel predictor of risk of overall mortality of CVD events in CKD. Meanwhile, loss of Klotho resulted from kidney dysfunction markedly contributes to the progressive development of CKD and CVD. By contrast, prevention of Klotho decline using exogenous supplementation or genetically activated ways by several mechanisms can dramatically mitigate cardiac dysfunction, prevent vascular calcification, and retard the progression of CKD-accelerated atherosclerosis. KEY MESSAGES: Klotho deficiency is proposed as a novel predictive biomarker as well as a pathogenic contributor to CVD events in CKD. In the future, Klotho may be a crucial potential therapeutic strategy to decrease the burden of CVD comorbidity with CKD in clinics.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1159/000509369
- Canonical
- link ↗
- Fetched
- 2026-10-26 MST
Cite this
APA
Bi, X., Yang, K., Zhang, B., & Zhao, J. (2020). The Protective Role of Klotho in CKD-Associated Cardiovascular Disease. <em>Kidney Diseases</em>. https://doi.org/10.1159/000509369
Vancouver
Bi X, Yang K, Zhang B, Zhao J. The Protective Role of Klotho in CKD-Associated Cardiovascular Disease. Kidney Diseases. 2020. doi:10.1159/000509369.
BibTeX
@article{xianjin2020ThePro,
title = {The Protective Role of Klotho in CKD-Associated Cardiovascular Disease},
author = {Xianjin Bi and Ke Yang and Bo Zhang and Jinghong Zhao},
journal = {Kidney Diseases},
year = {2020},
doi = {10.1159/000509369},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
BMC Nephrology 2018
Open access · CC-BY
The role of klotho in chronic kidney disease
American Journal of Kidney Diseases 2013
Preprint · CC-BY
Circulating α-Klotho Levels in CKD and Relationship to Progression
Libyan Journal of Medical Research 2025
Open access · CC-BY
Klotho gene transfection into mesenchymal stem cells as a potential therapy for kidney disease
PLoS ONE 2013
Open access · CC-BY
A Decreased Level of Serum Soluble Klotho Is an Independent Biomarker Associated with Arterial Stiffness in Patients with Chronic Kidney Disease
American Journal of Clinical Pathology 2012
Citation only
Validation of an Immunoassay for Soluble Klotho Protein
The international journal of biochemistry & cell biology 2026
Citation only